Asao Hirose

Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification

Ichiro Yonese, Chizuko Sakashita, Ken‐Ichi Imadome et al. · Blood Advances · 2020 · 87 citations · Full text

World Health Organization, Virus Epidemiology, Immunodeficiencies +23

Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib

Yoshiki Hayashi, Hirohisa Nakamae, Takako Katayama et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 59 citations

Mixed-phenotype Acute Leukemia, Immunology, Immune Regulation +21

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of <i>CDX2</i> and <i>IDH1/2</i> mutations

Takahiko Yasuda, Masashi Sanada, Masahito Kawazu et al. · Blood · 2021 · 49 citations · Full text

HLA haploidentical peripheral blood stem cell transplantation using reduced dose of posttransplantation cyclophosphamide for poor-prognosis or refractory leukemia and myelodysplastic syndrome

Hirohisa Nakamae, Hideo Koh, Takako Katayama et al. · Experimental Hematology · 2015 · 40 citations

Cell Therapy, Transplantation, Marrow Transplantation +11

A prospective observational study of immune reconstitution following transplantation with post‐transplant reduced‐dose cyclophosphamide from <scp>HLA</scp> ‐haploidentical donors

Hirohisa Nakamae, Kazuki Fujii, Satoru Nanno et al. · Transplant International · 2019 · 38 citations